These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 6084609)
21. Minor displacements in the insertion site provoke major differences in the induction of antibody responses by chimeric parvovirus-like particles. Rueda P; Hurtado A; del Barrio M; Martínez-Torrecuadrada JL; Kamstrup S; Leclerc C; Casal JI Virology; 1999 Oct; 263(1):89-99. PubMed ID: 10544085 [TBL] [Abstract][Full Text] [Related]
22. Mapping of type 1 poliovirus neutralization epitopes. Blondel B; Crainic R; Dufraisse G; Candréa A; Horaud F Dev Biol Stand; 1985; 60():337-42. PubMed ID: 2412917 [TBL] [Abstract][Full Text] [Related]
23. Studies of the antigenic variation in poliovirus type 1. Selection and analysis of variant strains with monoclonal antibodies by neutralization. Thibodeau L; Lacroix M; Lecomte J; Fauvel M Dev Biol Stand; 1984; 57():157-63. PubMed ID: 6084606 [TBL] [Abstract][Full Text] [Related]
24. [Antigen differences of genetic variants Abent+ and Abent- poliovirus vaccine strain of III type]. Shyrobokov VP; Kostenko IH; Nikolaienko IV Mikrobiol Z; 2003; 65(4):29-36. PubMed ID: 14618784 [TBL] [Abstract][Full Text] [Related]
25. Expression of a poliovirus neutralization epitope at the surface of recombinant bacteria: first immunization results. Charbit A; Van der Werf S; Mimic V; Boulain JC; Girard M; Hofnung M Ann Inst Pasteur Microbiol; 1988; 139(1):45-58. PubMed ID: 2454645 [TBL] [Abstract][Full Text] [Related]
26. Isolation of a recombinant type 3/type 2 poliovirus with a chimeric capsid VP1 from sewage in Shandong, China. Tao Z; Wang H; Xu A; Zhang Y; Song L; Zhu S; Li Y; Yan D; Liu G; Yoshida H; Liu Y; Feng L; Chosa T; Xu W Virus Res; 2010 Jun; 150(1-2):56-60. PubMed ID: 20206214 [TBL] [Abstract][Full Text] [Related]
27. Critical role of neighbouring sequences on the immunogenicity of the C3 poliovirus neutralization epitope expressed at the surface of recombinant bacteria. van der Werf S; Charbit A; Leclerc C; Mimic V; Ronco J; Girard M; Hofnung M Vaccine; 1990 Jun; 8(3):269-77. PubMed ID: 1694613 [TBL] [Abstract][Full Text] [Related]
28. Antigen chimaeras of poliovirus as potential new vaccines. Burke KL; Dunn G; Ferguson M; Minor PD; Almond JW Nature; 1988 Mar; 332(6159):81-2. PubMed ID: 2450279 [TBL] [Abstract][Full Text] [Related]
29. A neutralizing epitope on human rhinovirus type 2 includes amino acid residues between 153 and 164 of virus capsid protein VP2. Skern T; Neubauer C; Frasel L; Gründler P; Sommergruber W; Zorn M; Kuechler E; Blaas D J Gen Virol; 1987 Feb; 68 ( Pt 2)():315-23. PubMed ID: 2434607 [TBL] [Abstract][Full Text] [Related]
30. Antigenicity and immunogenicity of poliovirus capsid proteins. van Wezel AL; van der Marel P; Hazendonk TG; Boer-Bak V; Henneke MA Dev Biol Stand; 1983; 55():209-15. PubMed ID: 6203795 [TBL] [Abstract][Full Text] [Related]
31. [Structural polypeptide VP1 in poliovirus type 1 induced by neutralizing antibodies]. Blondel B; Crainic R; Horodniceanu F C R Seances Acad Sci III; 1982 Jan; 294(2):91-4. PubMed ID: 6282399 [TBL] [Abstract][Full Text] [Related]
32. Identification of a poliovirus neutralization epitope through use of neutralizing antiserum raised against a purified viral structural protein. Emini EA; Dorner AJ; Dorner LF; Jameson BA; Wimmer E Virology; 1983 Jan; 124(1):144-51. PubMed ID: 6186073 [TBL] [Abstract][Full Text] [Related]
33. Isolated poliovirus capsid protein VP1 induces a neutralizing response in rats. Chow M; Baltimore D Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7518-21. PubMed ID: 6296837 [TBL] [Abstract][Full Text] [Related]
34. Evolution of poliovirus during an outbreak: sequential type 3 poliovirus isolates from several persons show shifts of neutralization determinants. Huovilainen A; Hovi T; Kinnunen L; Takkinen K; Ferguson M; Minor P J Gen Virol; 1987 May; 68 ( Pt 5)():1373-8. PubMed ID: 2437244 [TBL] [Abstract][Full Text] [Related]
35. Identification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1. Leclerc C; Deriaud E; Mimic V; van der Werf S J Virol; 1991 Feb; 65(2):711-8. PubMed ID: 1702841 [TBL] [Abstract][Full Text] [Related]
36. Fine mapping of neutralization epitopes on duck hepatitis B virus (DHBV) pre-S protein using monoclonal antibodies and overlapping peptides. Chassot S; Lambert V; Kay A; Godinot C; Roux B; Trepo C; Cova L Virology; 1993 Jan; 192(1):217-23. PubMed ID: 7685963 [TBL] [Abstract][Full Text] [Related]
37. Antigenic sites on the receptor-binding domain of human adenovirus type 2 fiber. Fender P; Kidd AH; Brebant R; Oberg M; Drouet E; Chroboczek J Virology; 1995 Dec; 214(1):110-7. PubMed ID: 8525605 [TBL] [Abstract][Full Text] [Related]
38. Production of monoclonal and monospecific antibodies against non-capsid proteins of poliovirus. Pasamontes L; Egger D; Bienz K J Gen Virol; 1986 Nov; 67 ( Pt 11)():2415-22. PubMed ID: 2431100 [TBL] [Abstract][Full Text] [Related]
39. Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins: identification of T helper epitopes in VP1. Rodríguez A; Sáiz JC; Novella IS; Andreu D; Sobrino F Virology; 1994 Nov; 205(1):24-33. PubMed ID: 7526534 [TBL] [Abstract][Full Text] [Related]
40. Location and primary structure of a major antigenic site for poliovirus neutralization. Minor PD; Schild GC; Bootman J; Evans DM; Ferguson M; Reeve P; Spitz M; Stanway G; Cann AJ; Hauptmann R; Clarke LD; Mountford RC; Almond JW Nature; 1983 Feb; 301(5902):674-9. PubMed ID: 6186919 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]